Stage and Survival in Breast Cancer Patients in Screened and Non-screened Danish and Swedish Populations

Acta Oncologica

Volumn 42, Issue 7, 2003, Pages 701-709

  Jensen, Anni R ^a   Garne, Jens P ^a   Storm, Hans H ^b   Ewertz, Marianne ^c   Cold, Søren ^d   Alvegaard, Thor ^e   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e S Swedish Regional Tumour Registry   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASES; MAMMOGRAPHY; ONCOLOGY; PATIENT MONITORING;

MULTIVARIATE ANALYSIS; SURVIVAL;

TUMORS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; EARLY DIAGNOSIS; FEMALE; HUMAN; MAMMOGRAPHY; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; SWEDEN; TUMOR VOLUME;

AGED; BREAST NEOPLASMS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; TIME FACTORS;

EID: 0345449032     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310010556     Document Type: Article

References (24)

1. Engeland A, Haldorsen T, Dickman PW, et al. Relative survival of cancer patients - a comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59.
2. National Board of Health, Copenhagen Denmark. The Danish National Cancer Plan, II, epidemiologi. National Board of Health, Copenhagen, Denmark; 2000.
3. Tulinius H, Storm HH, Pukkala E, Andersen A, Ericsson J. Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic Cancer Registries. APMIS 1992; (Suppl 31): 1-194.
4. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS 1994; (Suppl 49): 1-161.
5. Engholm G, Christensen N, Storm HH. Improvement, but still a lower cancer survival in Denmark than in the other Nordic countries. Int J Cancer 2002; (Suppl 13): 89.
6. UICC, TNM classification of malignant tumours. 5th ed. 1997.
7. Tennvall-Nittby L, Tengrup I, Landberg T. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol 1993; 32: 641-6.
8. Andersen KW, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988; 27: 627-47.
9. Sant M, Capocaccia R, Coleman MP, et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37: 1659-67.
10. Jensen AR, Garne JP, Engholm G, Storm HH, Overgaard J. Breast cancer: a tale of two cities - comparison between two neighbouring countries: impact of mammography, early detection and axillary surgery. Int J Cancer 2002; (Suppl 13): 107.
11. Christensen L, Engholm G, Tange UB, et al. Can differences in classical prognostic parameters explain the 10% survival difference between Danish and Swedish women with breast cancer. Int J Cancer 2002; (Suppl 13): 107-8.
12. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989; 59: 954-8.
13. Buiatti E, Barchielli A, Bartolacci S, et al. Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy. Cancer Causes Control 2002; 13: 65-71.
14. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829-32.
15. Tubiana M, Koscielny S. Natural history of human breast cancer: recent data and clinical implications. Breast Cancer Res Treat 1991; 18: 125-40.
16. Tubiana M, Koscielny S. The rationale for early diagnosis of cancer - the example of breast cancer. Acta Oncol 1999; 38: 295-303.
17. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 1995; 13: 1144-51.
18. Koscielny S, Tubiana M, Le MG, et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 1984; 49: 709-15.
19. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. Bt Med J 1988; 297: 943-8.
20. Paci E, Giorgi D, Bianchi S, et al. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 2002; 38: 568-73.
21. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000; 355: 1822.
22. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359-77.
23. Barnes DM, Hanby AM. Oestrogen and progesterone receptors in breast cancer: past, present and future. Histopathology 2001; 38: 271-4.
24. Andreasen AH, Andersen KW, Madsen M, Mouridsen H, Olesen KP, Lynge E. Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screening. Br J Cancer 1994; 70: 133-7.